Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

TElomeric repeat-containing RNA (TERRA): Physiological functions and relevance in cancer

M. Kroupa, K. Tomasova, M. Kavec, P. Skrobanek, T. Buchler, R. Kumar, L. Vodickova, P. Vodicka

. 2022 ; 12 (-) : 913314. [pub] 20220802

Language English Country Switzerland

Document type Journal Article, Review

Telomeres are complex protective structures located at the ends of linear eukaryotic chromosomes. Their purpose is to prevent genomic instability. Research progress in telomere biology during the past decades has identified a network of telomeric transcripts of which the best-studied is TElomeric Repeat-containing RNA (TERRA). TERRA was shown to be important not only for the preservation of telomere homeostasis and genomic stability but also for the expression of hundreds of genes across the human genome. These findings added a new level of complexity to telomere biology. Herein we provide insights on the telomere transcriptome, its relevance for proper telomere function, and its implications in human pathology. We also discuss possible clinical opportunities of exosomal telomere transcripts detection as a biomarker in cancer precision medicine.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22023607
003      
CZ-PrNML
005      
20221031095127.0
007      
ta
008      
221010s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fonc.2022.913314 $2 doi
035    __
$a (PubMed)35982970
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kroupa, Michal $u Department of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University, Pilsen, Czechia
245    10
$a TElomeric repeat-containing RNA (TERRA): Physiological functions and relevance in cancer / $c M. Kroupa, K. Tomasova, M. Kavec, P. Skrobanek, T. Buchler, R. Kumar, L. Vodickova, P. Vodicka
520    9_
$a Telomeres are complex protective structures located at the ends of linear eukaryotic chromosomes. Their purpose is to prevent genomic instability. Research progress in telomere biology during the past decades has identified a network of telomeric transcripts of which the best-studied is TElomeric Repeat-containing RNA (TERRA). TERRA was shown to be important not only for the preservation of telomere homeostasis and genomic stability but also for the expression of hundreds of genes across the human genome. These findings added a new level of complexity to telomere biology. Herein we provide insights on the telomere transcriptome, its relevance for proper telomere function, and its implications in human pathology. We also discuss possible clinical opportunities of exosomal telomere transcripts detection as a biomarker in cancer precision medicine.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Tomasova, Kristyna $u Department of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University, Pilsen, Czechia
700    1_
$a Kavec, Miriam $u Department of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czechia
700    1_
$a Skrobanek, Pavel $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czechia
700    1_
$a Buchler, Tomas $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czechia
700    1_
$a Kumar, Rajiv $u Department of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia $u Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
700    1_
$a Vodickova, Ludmila $u Department of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University, Pilsen, Czechia $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Vodicka, Pavel $u Department of the Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University, Pilsen, Czechia $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czechia
773    0_
$w MED00182989 $t Frontiers in oncology $x 2234-943X $g Roč. 12, č. - (2022), s. 913314
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35982970 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20221010 $b ABA008
991    __
$a 20221031095125 $b ABA008
999    __
$a ind $b bmc $g 1853937 $s 1174895
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 12 $c - $d 913314 $e 20220802 $i 2234-943X $m Frontiers in oncology $n Front Oncol $x MED00182989
LZP    __
$a Pubmed-20221010

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...